Literature DB >> 19484865

End-stage renal disease and chronic kidney disease in Brazil.

Jocemir R Lugon1.   

Abstract

The world is facing an epidemic of chronic kidney disease (CKD). This report discusses the present state of chronic kidney disease care in Brazil. We report frequency of dialysis treatment and prevalence of kidney transplantation throughout Brazil. We estimated the number of CKD patients in the country through a mathematical extrapolation based on data generated by the NHANES. On January 2007, 73,605 patients were on dialysis, which corresponds to 390 patients per million of population (pmp); the majority of these patients (approximately 90%) were funded by the Brazilian Public Health System. If we aggregate patients with a functioning kidney graft, unofficially estimated by ABTO as 27,500 (approximately 150 pmp), the whole adjusted prevalence of end-stage renal disease patients in Brazil by January 2007 is approximately 540 pmp. We estimate that the number of patients with glomerular filtration rate < 60 mL/min/1.73 m2 of body surface approximates 15 million people in Brazil, many of whom are not in treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19484865

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  3 in total

1.  Global Dialysis Perspective: Brazil.

Authors:  Ricardo Sesso; Jocemir R Lugon
Journal:  Kidney360       Date:  2020-02-04

2.  Impact of adjusted kidney volume measured in the bench surgery on one-year renal function in kidney transplantation.

Authors:  Flávio Vasconcelos Ordones; Pedro Ivo Rocchetti Pajolli; Rodrigo Guerra da Silva; Hamilto Akihissa Yamamoto; Fernando Fereira Gomes Filho; Paulo Roberto Kawano; João Luiz Amaro; Luis Gustavo Modelli de Andrade
Journal:  PLoS One       Date:  2019-11-04       Impact factor: 3.240

3.  Study of the incidence of dialysis in São Paulo, the largest Brazilian city.

Authors:  Antonio Carlos Cordeiro; Juan Jesús Carrero; Abdul Rashid Qureshi; Ricardo Ferreira da Cunha; Bengt Lindholm; Isac de Castro; Irene Lourdes Noronha
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.